|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 14, 2017 ) In this region, global advanced wound care is projected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024.
Some of the major factors driving the growth of advanced wound care market are rising aging population, growing incidences of diabetes, technological advancement.
Based on geography, the global advanced wound care market is segmented into 5 geographical regions, such as,
North America,
South America,
Europe,
APAC,
MEA,
Rest Of the World
Global advanced wound care market competition by top players including -
Acelity L.P. INC. is going to dominate the Advanced Wound Care market following with
3M,
Smith and Nephew,
Medtronic,
Molnlycke Healthcare AB,
Convatec Inc,
Baxter,
Coloplast,
Ethicon. Inc,
Hollister Inc,
Integra Life Sciences Corporation,
Request a sample copy at http://www.reportsweb.com/inquiry&RW00011159373/sample
Derma Sciences Inc,
Spiracur Inc,
Medline Industries,
Mimedx Group,
Organogenesis Inc,
Talley Group,
BSN Medical,
Devon Medical Products,
Human Biosciences Inc,
B.Braun Melsungen AG,
Cardinal Health,
Paul Hartmann Limited,
DeRoyal Industries Inc,
DermaRite Industries LLC,
MPM Medical Inc,
Kinetic Concepts,
Advancis Medical.
The global advanced wound care market is segmented into three product types, namely, dressing, biologics, and therapy devices. However, biologics segment is expected to grow at the highest CAGR in the forecast period.
Based on dressing type, the market is segmented into foam dressing, hydrogels, film dressings, alginates, wound contact layer and super absorbent dressing. In 2017, film dressing segment is expected to dominate the global advanced wound care market.
Based on biologics type, the market is segmented synthetic into skin grafts, growth factors, allografts and xenografts.
Based on wound care growth factor type, the market is segmented into platelet derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), talactoferrin ALFA, thrombin peptide (TP508) and keratinocyte growth factor (KGF).
Inquire for Report at http://www.reportsweb.com/inquiry&RW00011159373/buying
Based on wound care therapy devices type, the market is segmented into negative pressure wound therapy (NPWT), pressure relief devices (PRD), wound debridement devices, hyberbaric oxygen chambers and physical therapies.
Based on NPWT type, the market is segmented into stand alone NPWT devices, portable NPWT devices and disposable NPWT devices.
Based on PRD type, the market is segmented into mattress and bed.
Based on hyberbaric oxygen chambers type, the market is segmented into monoplace, multiplace and topical.
Based on wound debridement devices type, the market is segmented into hydrosurgical, ultrasound, and mechanical among others.
Based on physical therapies type, the market is segmented into laser therapy, electrical simulation, external shock wave therapies and saline mist therapy.
Based on wound type, the market is segmented into surgical wound, diabetic ulcer, burns, pressure ulcer, venous ulcer among others. Diabetic ulcers segment is expected to grow at the highest CAGR of in the forecast period.
On the basis of end users, the market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.
On the basis of distribution channel the market is segmented into direct tenders, and retails.
Companies Mentioned
3M
Smith and Nephew
Medtronic
Molnlycke Healthcare AB
Convatec Inc
Baxter
Coloplast
Ethicon. Inc
Hollister Inc
Integra Life Sciences Corporation
Derma Sciences Inc
Spiracur Inc
Medline Industries
For more information about this report at http://www.reportsweb.com/global-advanced-wound-care-market-analysis-and-forecast-to-2024
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
